Tekmira to suspend Ebola drug development, focus on hepatitis B
Monday, July 20, 2015 - 11:30
in Mathematics & Economics
Tekmira Pharmaceuticals Corp., based in Burnaby, B.C., announced on Monday that their TKM-Ebola drug will no longer be produced.